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Abstract
Background
The sole report of annual leptospirosis incidence in continental Africa of 75–102 cases per
100,000 population is from a study performed in August 2007 through September 2008 in
the Kilimanjaro Region of Tanzania. To evaluate the stability of this estimate over time, we
estimated the incidence of acute leptospirosis in Kilimanjaro Region, northern Tanzania for
the time period 2012–2014.
Methodology and Principal Findings
Leptospirosis cases were identified among febrile patients at two sentinel hospitals in the
Kilimanjaro Region. Leptospirosis was diagnosed by serum microscopic agglutination test-
ing using a panel of 20 Leptospira serovars belonging to 17 separate serogroups. Serum
was taken at enrolment and patients were asked to return 4–6 weeks later to provide conva-
lescent serum. Confirmed cases required a 4-fold rise in titre and probable cases required a
single titre of800. Findings from a healthcare utilisation survey were used to estimate mul-
tipliers to adjust for cases not seen at sentinel hospitals. We identified 19 (1.7%) confirmed
or probable cases among 1,115 patients who presented with a febrile illness. Of cases, the
predominant reactive serogroups were Australis 8 (42.1%), Sejroe 3 (15.8%), Grippoty-
phosa 2 (10.5%), Icterohaemorrhagiae 2 (10.5%), Pyrogenes 2 (10.5%), Djasiman 1
(5.3%), Tarassovi 1 (5.3%). We estimated that the annual incidence of leptospirosis was
11–18 cases per 100,000 population. This was a significantly lower incidence than 2007–08
(p<0.001).
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Conclusions
We estimated a much lower incidence of acute leptospirosis than previously, with a notable
absence of cases due to the previously predominant serogroup Mini. Our findings indicate a
dynamic epidemiology of leptospirosis in this area and highlight the value of multi-year sur-
veillance to understand leptospirosis epidemiology.
Author Summary
Leptospirosis is an infectious disease that causes a fever. It can be severe or fatal. Under-
standing how many people get leptospirosis helps to determine priorities in allocating
resources for disease diagnosis, treatment, and prevention. There are few data about lepto-
spirosis incidence in sub-Saharan African countries. The only mainland estimate is from
northern Tanzania for the years 2007–08. To see if leptospirosis incidence had changed
since 2007–08, we measured leptospirosis incidence in the same location in 2012–2014.
To do this, we systematically approached people at two hospitals in the Kilimanjaro
Region and tested them for leptospirosis. We adjusted the number of identified cases of
leptospirosis found at the hospitals to account for people with fever who did not come to
hospital for testing and care. We also adjusted for imperfect testing methods. We found
that the number of people who developed leptospirosis annually had dropped from 75–
102 cases per 100,000 people during 2007–08 to 11–18 cases per 100,000 people during
2012–14. Also, the subtype of leptospirosis responsible for the most cases during 2007–08
was not present during 2012–14. The number of people developing leptospirosis was not
stable, highlighting the value of measuring how commonly leptospirosis occurs over sev-
eral years.
Introduction
Leptospirosis is a major cause of illness worldwide with an estimated 1.03 million cases, 59,000
deaths, and 2.90 million disability adjusted life years lost annually [1, 2]. The burden of disease
is thought to be greatest in tropical countries, although reported estimates of incidence in con-
tinental Africa are scarce [3, 4]. Accurate estimates of incidence are important for estimation
of disease burden and consequently, appropriate allocation of resources for diagnosis, treat-
ment, and prevention. Challenges in estimating incidence that may account for the scarcity of
reports of incidence in Africa include lack of availability of diagnostic tests [5], low clinician
awareness [6], and non-specific presentation.
Although active, population-based surveillance is an ideal method for accurately determin-
ing incidence, resource and logistic challenges often preclude its use. Multiplier methods have
been used successfully to estimate the incidence of acute infectious diseases in resource-limited
settings by extrapolating from hospital based data [7, 8]. Specifically, multiplier methods were
used to determine the incidence of acute leptospirosis in the Kilimanjaro Region during 2007–
08 [9]. Using hospital based prevalence data and multipliers from a linked health-care seeking
behaviour survey [10], the annual incidence of acute leptospirosis was estimated as 75–102
cases per 100,000 [9]. This estimate of incidence based on empirical data was substantially
higher than an estimate (7–38 cases per 100,000 population) for Tanzania based on a model-
ling approach using incorporated data from a systematic review of risk factors [2].
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Leptospirosis may cause endemic disease, but is also capable of causing epidemics during
flooding or other extreme weather events [11]. As such, data gathered from the same location
from multiple time periods can provide insights into the dynamics of disease incidence over
time, distinguish periods of endemic and epidemic transmission, and help determine more
representative burden of disease estimates.
We sought to estimate the incidence of acute leptospirosis in northern Tanzania from 2012
until 2014 using a similar methodology to the previous estimate in the same region in order to
describe trends over multiple year periods.
Methods
We calculated the incidence of acute leptospirosis using a multiplier study design. Briefly, we
combined a healthcare utilisation survey performed in two districts within the Kilimanjaro
Region with a hospital-based surveillance involving systematic evaluation for leptospirosis in
febrile patients at the two major referral hospitals in the Kilimanjaro Region. We multiplied
the number of identified cases of acute leptospirosis by a number of factors designed to
account for incomplete data using the surveillance pyramid model (Fig 1.) [9].
Fever surveillance
Study Site: We studied patients at two referral hospitals in Moshi, Tanzania. Moshi is the
administrative centre for the Kilimanjaro Region that has a population of 1.6 million. Moshi is
situated at an elevation of approximately 890m and has a tropical climate with rainy seasons
from October through December and March through May. Aside from urban Moshi, the
region is rural with inhabitants practicing cultivation and small-holder farming. Kilimanjaro
Christian Medical Centre (KCMC) is a 450 bed hospital and the zonal referral centre for sev-
eral regions in Northern Tanzania. Mawenzi Regional Referral Hospital (MRRH) is a 300 bed
hospital and the referral centre for the Kilimanjaro region.
Enrolment procedures: From 20 February 2012 through 28 May 2014 the study team
approached all adult patients who were admitted to KCMC with a febrile illness as well as all
adult or paediatric patients who were admitted at MRRH. In addition we approached every
second patient who presented with fever to the outpatient department at MRRH. Hospitalized
participants were eligible for enrolment if they had a history of fever within the previous 72
hours or an axillary temperature of>37.5˚C or a tympanic, oral or rectal temperature of
38.0˚C at admission. Non-hospitalized patients were eligible if they had an axillary tempera-
ture of>37.5˚C or a tympanic, oral or rectal temperature of38.0˚C. All adult study partici-
pants provided written informed consent. For those under 18 years, a parent or guardian
provided written informed consent. In addition, written assent was provided for those aged 12
to 18 years. This study differed from the previous Kilimanjaro Region incidence study in its
enrolment of outpatients and the enrolment of children at MRRH rather than at KCMC.
Enrolment occurred only on weekdays. Enrolled patients underwent phlebotomy, with
blood allocated for acute leptospirosis serology only if there was sample available after blood
parasite microscopy and blood culture. Participants were requested to return for collection of
convalescent serum 4–6 weeks after enrolment. For those who did not attend the scheduled
follow up, we attempted to contact them and encourage attendance. Additionally, we recorded
inpatient death. Unlike the previous study estimating leptospirosis incidence in the Kiliman-
jaro Region, we did not record inter-hospital transfer.
Laboratory methods: Serology for leptospirosis was performed on acute and convalescent
serum samples using the standard microscopic agglutination test (MAT) with a panel of 20
Leptospira serovars belonging to 17 serogroups at the United States Centers for Disease
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Control and Prevention. These included serogroups: Australis (represented by L. interrogans
serovar Australis, L. interrogans serovar Bratislava), Autumnalis (L. interrogans serovar
Autumnalis), Ballum (L. borgpetersenii serovar Ballum), Bataviae (L. interrogans serovar Bata-
viae), Canicola (L. interrogans serovar Canicola), Celledoni (L. weilii serovar Celledoni),
Cynopteri (L. kirschneri serovar Cynopteri), Djasiman (L. interrogans serovar Djasiman),
Grippotyphosa (L. interrogans serovar Grippotyphosa), Hebdomadis (L. santarosai serovar
Borincana), Icterohaemorrhagiae (L. interrogans serovar Mankarso, L. interrogans Icterohae-
morrhagiae), Javanica (L. borgpetersenii serovar Javanica), Mini (L. santarosai serovar Geor-
gia), Pomona (L. interrogans serovar Pomona), Pyrogenes (L. interrogans serovar Pyrogenes, L.
santarosai serovar Alexi), Sejroe (L. interrogans serovar Wolffi), and Tarassovi (L. borgpeterse-
nii serovar Tarassovi).
Fig 1. Surveillance pyramid showing multipliers used to account for incomplete case identification. Modified from Biggs HM, Hertz JT,
Munishi OM, Galloway RL, Marks F, Saganda W, et al. Estimating leptospirosis incidence using hospital-based surveillance and a population-
based health care utilization survey in Tanzania. PLoS Negl Trop Dis. 2013;7(12):e2589.
doi:10.1371/journal.pntd.0005165.g001
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Case definitions: We defined confirmed acute leptospirosis as participants who demon-
strated a four-fold rise in agglutinating antibody titres between acute and convalescent serum
samples. Cases were defined as probable if a participant’s serum had a single agglutinating titre
of at least 1:800. These definitions were identical to those used to obtain the previous incidence
estimate [9, 12]. The predominant reactive serogroup, for confirmed cases was defined as the
serogroup containing the serovar with the largest rise in titres between acute and convalescent
sera. For probable cases, we used the serovar with the highest titre to define the serogroup.
Derivation of multipliers
A time multiplier of 1.40 was used to account for enrolment occurring only on weekdays (5 of
every 7 days). Additionally a study duration multiplier of 0.44 was included to calculate annual
incidence from a study that enrolled for 27 months (20 February 2012 through 28 May 2014).
We applied enrolment and blood draw multipliers to account for eligible patients who either
did not enrol or for whom blood was not available for leptospirosis serology. Calculations of
these multipliers are presented in the results. We were unable to include a transfer multiplier
in the current study as details of inter-hospital transfer of participants were not recorded. For
the estimation of incidence based solely on confirmed cases, a paired sera multiplier was
applied to account for those patients who did not have paired sera drawn. Diagnostic test mul-
tipliers were used to account for the sensitivity and specificity of MAT serology. The sensitivity
was estimated at 100% for paired sera, 48.7% for participants with solely acute sera and 93.8%
for those with solely convalescent sera. The specificity was estimated at 93.8%. The estimates
are based on a published evaluation of diagnostic tests [9, 13] and matched those used in the
2007–08 study.
Healthcare utilisation survey
A healthcare utilisation survey was carried out in the Moshi Urban (population 184,292) and
Moshi Rural (population 466,737) Districts of Kilimanjaro Region between 13 June and 22
July 2011 as previously reported [9, 14]. Briefly, 30 of the 45 wards were selected randomly
using a population-weighted approach. A study member collected data from the heads of the
first 27 households encountered within the ward. A total of 810 households were sampled,
comprising 3,919 household members. All households had at least one member >15 years of
age, 361 had at least one member aged between 5 and 15 years of age, and 198 households had
at least one member aged below 5 years. The demographic characteristics from the healthcare
utilisation survey have been previously compared to the 2002 Tanzanian Census [9]. Age spe-
cific population data has not yet been released from the 2012 Census [14]. Questions relating
to health-care seeking behaviour in the event of febrile illness were used to identify participants
likely to present to KCMC or MRRH. These questions included, ‘what is the name of the health
care facility with an inpatient ward where you/your family would go if you/your family had
fever?’ and ‘what will you do if a [household member subdivided by age bracket] has a fever
for≧ 3 days?’. The hospital multipliers are presented in Table 1. Each multiplier is the recipro-
cal of the proportion of survey participants who responded that they would attend KCMC or
MRH as their first or second choice healthcare provider.
Population denominators
We used population totals from the 2012 census [14]. As age specific population data were not
available from the 2012 census, we multiplied age specific proportions from the 2002 census by
the 2012 population total to estimate age-specific populations. The 2007–2008 Kilimanjaro
Region incidence estimate used population totals from the 2002 census.
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Comparison of incidence between study periods
We compared incidence by using the estimate of incidence derived from confirmed and prob-
able cases from each of the study periods and the estimated population sampled as the denomi-
nator. As shown in Table 2, the estimated population sampled was calculated by multiplying
the total population by the proportion of participants in the healthcare utilization survey that
identified KCMC or MRRH as hospitals they would attend in the event of febrile illness. We
compared the highest estimates of incidence in each of the study periods.
Sensitivity Analysis
We repeated all calculations using both probable and confirmed cases and then using con-
firmed cases only. Additionally we performed a one-way sensitivity analysis by varying hospi-
tal multipliers according to answers to alternative relevant questions in the healthcare
utilisation survey that might also reflect the behaviour of participants and diagnostic test mul-
tipliers by using a range of alternative plausible sensitivity values for MAT [15–17].
Statistical analysis
Data was entered using the Cardiff Teleform system (Cardiff, Inc., Vista, CA, USA) into an
Access database (Microsoft Corporation, Redmond, WA, USA). Incidence calculations were
carried out using Microsoft Excel 2010 (Microsoft Corporation. Redmond, WA, USA)
Table 1. Multipliers based on responses to relevant questions in healthcare utilisation survey, Moshi Rural and Moshi Urban Districts, Tanzania,
2011.
Age, years Households KCMC MRRH KCMC % MRRH % KCMC mult. MRRH mult.
What will you do if a [household member] has a fever for ≧ 3 days?
<5 198 17 67 8.6 33.8 11.6 3.0
5 to 15 361 10 137 2.8 38.0 36.1 2.6
≧15 810 35 299 4.3 36.9 23.1 2.7
What is the name of the health care facility with an inpatient ward where you/your family would go if you/your family had fever?
<5 198 10 68 5.1 34.3 19.8 2.9
5 to 15 361 28 133 7.8 36.8 12.9 2.7
≧15 810 50 313 6.2 38.6 16.2 2.6
KCMC: Kilimanjaro Christian Medical Centre
MRRH: Mawenzi Regional Referral Hospital
Mult.: multiplier
doi:10.1371/journal.pntd.0005165.t001
Table 2. Estimated population of Moshi Urban and Moshi Rural District that reported that they would attend KCMC or MRRH if they developed a
febrile illness during the time periods 2007–08 and 2012–14.
Age,
years
Population
2007–08
Population
2012–14
Proportion
attending KCMC
Proportion
attending MRRH
Estimated population
sampled 2007–2008
Estimated population
sampled 2012–2014
<5 68,680 82,016 0.09 0.34 6,212 27,613
5 to 15 150,218 179,387 0.03 0.38 4,138 67,703
15 326,270 389,625 0.04 0.37 134,536 160,660
Total 545,168 651,028 144,887 255,976
KCMC: Kilimanjaro Christian Medical Centre
MRRH: Mawenzi Regional Referral Hospital
doi:10.1371/journal.pntd.0005165.t002
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spreadsheets. Other analyses were performed using STATA, version 13.1 (STATA-Corp, Col-
lege Station, TX, USA). We used a test of proportions to compare the incidence between
2007–08 and 2012–14. All p values are 2 sided and statistical significance was set at p<0.05.
Research ethics
This study was approved by the KCMC Research Ethics Committee (#295), the Tanzania
National Institutes for Medical Research National Ethics Co-ordinating Committee
(NIMR1HQ/R.8cNo1. 11/283), the Institutional Review Board of Duke University Medical
Center (IRB#Pro00016134) and the University of Otago Human Ethics Committee (Health)
(H15/055).
Results
Fever surveillance
Of 1,115 participants enrolled from within the study districts, 1,017 (91.2%) had blood drawn
for leptospirosis testing. Of the 1,115 participants, 409 (37.7%) <5 years, 111 (10.0%) 5–14
years, and 595 (53.4%) were aged15 years. A total of 593 (46.9%) participants were male. A
total of 758 (74.6%) participants reported having a fever for at least 3 days.
Of 1,017 participants tested for leptospirosis, 12 (1.2%) met the case definitions for con-
firmed leptospirosis and an additional 7 (0.7%) met the case definitions for probable acute lep-
tospirosis. The predominant reactive serogroups among confirmed and probable cases of
leptospirosis are summarised in Table 3.
Of both confirmed and probable cases, there were seven (1.7%, 95% confidence interval
[CI] 0.4–2.9%) cases among 416 outpatients and 12 (1.9%, 95% CI 0.8–3.1%) cases among 601
inpatients. There was no statistically significant difference in the prevalence of leptospirosis
between inpatients and outpatients (p = 0.72).
Multipliers. Because the residence of those who declined to participate was not recorded,
the enrolment multiplier was calculated for participants residing in both study and non-study
districts. As 1,420 (59.3%) of 2,394 eligible patients were enrolled, we applied an enrolment
multiplier of 1.69. Age was also not recorded among those who did not participate, so age-spe-
cific enrolment multipliers were not calculated. Of the 1,115 participants enrolled, 1017
Table 3. Frequency of confirmed and probable acute leptospirosis defined by predominant reactive Leptospira serogroup, Moshi Rural and
Moshi Rural Districts, Tanzania, 2007–8 and 2012–14.
Leptospira serogroup Study Year
2007–08 (n = 41) 2012–14 (n = 19)
N (%) N (%)
Mini 15 (36.6) 0 (0)
Australis 14 (34.1) 8 (42.1)
Celledoni 4 (9.8) 0 (0)
Autumnalis 3 (7.3) 0 (0)
Icterohaemorrhagiae 1 (2.4) 2 (10.5)
Tarassovi 1 (2.4) 1 (5.3)
Djasiman 1 (2.4) 1 (5.3)
Hebdomadis 1 (2.4) 0 (0)
Sejroe 0 (0) 3 (15.8)
Pyrogenes 0 (0) 2 (10.5)
Grippotyphosa 0 (0) 2 (10.5)
doi:10.1371/journal.pntd.0005165.t003
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(91.2%) were tested for leptospirosis and age-specific blood draw multipliers were calculated
as shown in Table 4. A paired sera multiplier of 1.60 was applied to incidence calculations
involving confirmed cases only as 637 (62.6%) of 1,017 patients who had serum drawn had
paired sera tested for leptospirosis. Of the 380 who were lost to follow up or were otherwise
unable to provide both acute or convalescent sera, 173 (45.5%) were aged<5 years, 21 (5.5%)
were aged 5–14 years, 186 (49.6%) of 380 were aged15 years and 180 (47.4%) were male.
Incidence calculation
The annual incidence of acute leptospirosis in the Moshi Urban and Rural Districts (2012–
2014) was 11–18 cases per 100,000 population using hospital multipliers derived from the
question ‘To which facility would you go if you were unwell with a fever lasting≧3 days?’.
When using respnses to the question, ‘What is the name of the health care facility with an inpa-
tient ward where you/your family would go if you/your family had fever?’ the incidence was
9–18 cases per 100,000 population. The annual incidence was highest in adults, ranging from
13 to 29 cases per 100,000 population. Details of the calculation and age-specific incidences are
included in Table 5. The estimated incidence for confirmed and probable cases was (18 cases
per 100,000 population) was statistically significantly lower than the estimate of 102 cases per
100,000 population from 2007–08 (p<0.0001).
Estimates of annual incidence in six monthly time blocks is summarised in Table 6. These
data show a higher incidence during the first few months of the study.
Sensitivity Analysis
The results of the one-way sensitivity analysis are presented in Table 7. When we derived hos-
pital multipliers from alternative questions from the healthcare utilisation survey that might
also reflect the behaviour of participants, the estimated annual incidence ranged from 8–37
cases per 100,000 population. When we varied the estimated sensitivity of MAT from the low-
est to highest plausible values [5, 13, 16, 18, 19], the estimated annual incidence varied from
10–25 cases per 100,000 population.
Discussion
This study highlights the dynamic nature of leptospirosis epidemiology in the Kilimanjaro
Region, Tanzania. Our study shows that both incidence and serogroup dominance among
human cases have changed. The overall annual estimate of 11–18 cases of acute leptospirosis
per 100,000 population is substantially lower than the estimated incidence of 75–102 cases per
100,000 population per year from 2007–08 [9]. In addition the age-specific incidence appears
to have changed, with children estimated to have a lower incidence than in the 2007–08 study.
Despite the lower incidence during 2012–14, leptospirosis still appears to be an important
cause of fever in our region.
Table 4. Calculation of blood-draw multipliers, Moshi Rural and Moshi Urban Districts, Tanzania,
2012–14.
Age, Enrolled Blood Drawn Multiplier
years N N (%)
<5 431 350 (82) 1.2
5–15 111 109 (98) 1.0
≧15 573 558 (97) 1.0
doi:10.1371/journal.pntd.0005165.t004
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The explanation for the wide variation in incidence is uncertain, but may reflect changes in
climatic conditions, transient presence of an infected reservoir host, changes in human-animal
interactions, or changes in rodent-livestock interactions. Regarding climate, leptospirosis is
recognised as an important public health problem following extreme weather events in other
parts of the world such as Malaysia, Philippines, and Thailand [11]. The strong El Niño
Table 5. Calculation of incidence of acute leptospirosis, Moshi Rural and Moshi Urban Districts, Tanzania, 2012–14.
Age
group,
years
KCMC
crude
cases
KCMC
adjusted
cases
MRRH
crude
cases
MRRH
adjusted
cases
Total
adjusted
cases
Paired
sera
Days/
Week
Enrolment/
Blood draw
Study
duration
Estimated
annual
cases
Population Annual
Incidence
per 100,000
Based on the question: To which facility would you go if you were unwell with a fever lasting3 days?
Confirmed and probable cases
<5 N/A N/A 2 6 6 N/A 1.4 2.1 0.4 7 82,016 9
5 to 15 N/A N/A 0 0 0 N/A 1.4 1.7 0.4 0 179,387 0
≧15 3 67 14 57 62 N/A 1.4 1.4 0.4 67 389,625 17
Overall 75 651,028 11
Confirmed only
<5 N/A N/A 1 3 3 1.6 1.4 2.1 0.4 6 82,016 7
> = 5 to
<15
N/A N/A 0 0 0 1.6 1.4 1.7 0.4 0 179,387 0
≧15 3 67 8 33 50 1.6 1.4 2.2 0.4 111 389,625 28
Overall 117 651,028 18
Based on the question: What is the name of the health care facility with an inpatient ward where you/your family would go if you/your family had
fever?
Confirmed and Probable
<5 N/A N/A 2 5 5 N/A 1.4 2.1 0.4 7 82,016 9
5 to 15 N/A N/A 0 0 0 N/A 1.4 1.7 0.4 0 179,387 0
≧15 3 47 14 45 46 N/A 1.4 1.4 0.4 50 389,625 13
Overall 3 57 651,028 9
Confirmed only
<5 N/A N/A 1 2 2 1.6 1.4 2.1 0.4 7 82,016 8
5 to 15 N/A N/A 0 0 0 1.6 1.4 1.7 0.4 0 179,387 0
≧15 3 47 8 40 44 1.6 1.4 2.2 0.4 113 389,625 29
Overall 120 651,028 18
KCMC: Kilimanjaro Christian Medical Centre
MRRH: Mawenzi Regional Referral Hospital
N/A: Not applicable
doi:10.1371/journal.pntd.0005165.t005
Table 6. Incidence of acute leptospirosis in six months intervals, Moshi Rural and Moshi Urban Districts, Tanzania, 2012–14.
Time Period Participants Crude Cases Annual Incidence per 100,000
N N (%)
18 Feb—30 Jun 2012* 256 8 (3.1) 24
1 Jul– 31 Dec 2012 222 2 (0.9) 6
1 Jan– 30 Jun 2013 285 4 (1.4) 8
1 Jul– 31 Dec 2013 218 5 (2.3) 9
1 Jan– 30 Jun 2013 116 0 (0) 0
* 4 month time interval
doi:10.1371/journal.pntd.0005165.t006
The Incidence of Leptospirosis in the Kilimanjaro Region of Tanzania
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005165 December 2, 2016 9 / 15
conditions of 2006–07 were associated with flooding and epidemics of other diseases, such as
Rift Valley Fever. El Niño conditions may have influenced leptospirosis incidence during
2007–08 [20–22]. Urbanisation or reduced livestock ownership are unlikely to explain the
change in incidence, because, firstly population increased in rural areas between the 2002 and
2012 censuses and secondly livestock numbers are thought to have increased over the study
period [14, 23]. Livestock vaccination coverage to any disease remains low in Tanzania, and
we think that increased vaccination against leptospirosis is unlikely to account for the reduced
incidence [23].
There has also been a change in the most common predominant reactive serogroup. During
2007–08, serogroup Mini was the most commonly implicated serogroup, whereas during
2012–2014 there were no cases of leptospirosis in which Mini was the dominant serogroup [24].
Our findings are consistent with an interpretation of unstable serogroup transmission dynam-
ics, with increased transmission of a serovar from within the Mini serogroup during 2007–08.
Research to understand the reservoir hosts, sources, and risk factors for serogroup Mini in
northern Tanzania may help to explain the apparent unstable transmission. Aside from the
fever surveillance work at KCMC and MRRH in 2007–08, there are no reports of Leptospira ser-
ovars belonging to the Mini serogroup causing human disease in East Africa, although Mini ser-
ovars have been isolated from people and small mammals in the western Indian Ocean islands
of Mayotte and Madagascar [25–28]. Mini is an uncommonly tested serogroup, but serological
reactivity to Mini has been shown in cattle [29–32], wild game animals [33, 34], and rodents
[35]. Pilot serological study of cattle slaughtered for meat in Moshi Municipal District in 2014
found seroreactivity to L. borgpetersenii serovar Mini in 14 (24.1%) out of 58 animals tested
[36]. This finding indicates that livestock may be an important source for human leptospirosis
in the area. In addition, our data from both humans and livestock suggests that a representative
of the Mini serogroup should be included in future MAT panels in East Africa.
In 2012–14, the most common predominant serogroup was Australis, which was the second
most commonly identified predominant reactive serogroup during 2007–08. Agglutination
was observed against both test serovars (L. interrogans serovar Australis and L. interrogans ser-
ovar Bratislava) in 2007–08 and 2012–14. Continued identification of this serogroup suggests
that at least one serovar from the Australis serogroup is endemic in the region. Serovars from
Table 7. Sensitivity analysis of leptospirosis incidence, Moshi Rural and Moshi Urban Districts, Tan-
zania, 2012–14.
Variable Cases per 100,000
population)
Variation in multipliers based on varying the question from the
healthcare utilisation survey
Question: What will you do if a [household member subdivided by age bracket]
has a fever lasting <3 days?
25–37
Question: What will you do if a [household member subdivided by age bracket]
has a fever [duration not specified]?
32–49
Variations in estimation of sensitivity of MAT
Lowest plausible estimate 17–25
Paired sera: 75%
Solely acute sera: 6%
Solely convalescent sera: 70%
Highest plausible estimate 10–14
Sensitivity paired sera: 100%
Sensitivity acute sera only: 95%
Sensitivity convalescent sera only: 95%
doi:10.1371/journal.pntd.0005165.t007
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the Australis serogroup have been isolated from rodents in Tanzania [37], a human in Kenya
[38], an African grass rat in Nigeria [39] and cattle in Zimbabwe [40]. Serologic studies of ani-
mals in East Africa, have reported infrequent sero-reactivity to Australis serogroup in sheep,
goats and pigs [41] and cattle [42]. Seroreactivity against serogroup Australis serovars was also
observed in cattle slaughtered for meat in the Moshi area in 2014 [36]. Rural residence has pre-
viously been identified as a risk factor for acute leptospirosis in northern Tanzania [24]. These
findings raise the possibility of livestock as an important source of infection. However, care is
needed in interpreting infecting Leptospira strains from serological data as cross-reactions
between Mini, Sejroe, and Hebdomadis serogroups are common and using serological data to
infer infecting serovars is unreliable [43, 44]. Therefore, Leptospira spp. isolates from humans
and animals, and studies investigating risk factors are needed.
One of our study’s strengths is that the estimate of incidence used the same hospital surveil-
lance system and the same healthcare utilisation survey within the same districts as the earlier
study, allowing a direct comparison of distinct time periods. Differences in enrolment prac-
tices and multipliers between the 2007–08 incidence estimate and the current study may have
influenced the difference in estimated incidence. The 2012–14 study enrolled both those hos-
pitalised and those treated as outpatients, where as the 2007–08 study enrolled only inpatients.
However, in our study, the incidence did not vary by admission status. Other minor alterations
in multipliers include the addition of a blood-draw multiplier and the omission of a transfer
multiplier as these data were not collected. These multipliers ranged from 0.7–1.2 and if
applied, would have widened the apparent difference between incidence estimates from 2007–
08 and 2012–2014. The human population of the study area has been estimated from the 2012
census in the 2012–14 study and the 2002 census for the study of Biggs et al. The total popula-
tion rose from 545,168 to 651,028 between 2002 and 2012 [14]. It is likely therefore that the
2007–08 study underestimated the true population at the time of the study, and consequently
will have overestimated the incidence by a small margin.
There are other limitations in our study that influence interpretation of the results. We
chose to estimate incidence using multiplier methods as resource limitations precluded active
surveillance in the entire population. Although it is an accepted method of incidence estima-
tion, it means our estimate is based on a small number of cases, and some of the variation may
be due to random error. In addition multiplier methods rely on many assumptions. In particu-
lar, we assumed that those who presented to the two tertiary referral hospital study sites were
representative of the community sampled in the healthcare utilisation survey and that the care
seeking behaviour of those surveyed is representative of the population. We are unaware of
any substantial changes to the health system or health seeking behaviour from 2007 through
2014, and hence any healthcare utilisation survey error is likely to be consistent between the
studies. In the 2007–08 study, Biggs et al identified differences between the age and sex distri-
bution of the 2002 census population and those who participated in the healthcare utilisation
survey [9]. We were unable to compare the demographics of the population in the 2012 census
to those who took the healthcare utilisation survey but it is possible that the survey respondents
are not representative. In order to understand the effect that changes in care-seeking behaviour
would have on our estimate, we have performed a sensitivity analysis to provide a range of esti-
mates. In this sensitivity analysis we varied the multipliers according to different questions
from the healthcare utilization survey asking about fever shorter than 3 days. The larger multi-
pliers derived by these questions reflect the fact that patients with shorter durations of fever
are less likely to present to tertiary hospitals. We think that these estimates are less accurate
than our final estimate as three quarters of our participants reported a fever of at least 3 days.
We are likely to have underestimated the incidence of disease through our use of serological
diagnosis and enrolment from referral hospitals and may have biased inclusion towards those
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with severe disease. Firstly, we assumed that those who provided serum for testing were similar
to those who did not. Secondly, we used test multipliers to attempt to account for the insensi-
tivity of MAT in the acute phase of illness. We performed calculations using a sensitivity of
100% for MAT on paired serum samples and 48% for MAT on those providing only acute
serum samples to ensure comparability with the 2007–08 incidence estimate. However, there
is increasing evidence that MAT is less sensitive than the values of 100% for paired sera and
48.7% for solely acute serum that we used. It is therefore likely that the true incidence is
towards the upper end of the estimate in our sensitivity analysis [16, 18, 19].
In conclusion, our study demonstrates substantial variation in leptospirosis incidence
between time periods at the same site in continental Africa. Leptospirosis incidence appears to
have declined from 2007–08 to 2012–14, although it remains an important cause of fever. This
appears partly due to unstable transmission of a serovar from within the Mini serogroup. Our
findings indicate the value of leptospirosis surveillance over multiple year time periods to
understand the epidemiology of the disease. Our findings also highlight that much more work
is needed to identify the animal reservoirs of Leptospira spp. in Africa in order to understand
the human epidemiology.
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